Search
for
Sort by
Research 391–420 of 1000+
- Inhibiting Janus kinases to treat alopecia areata
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Janus kinase inhibitors for alopecia areata
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- 378 Treatment of severe alopecia areata with the oral Janus kinase inhibitor, tofacitinib: A retrospective chart review
- The Role of Janus Kinase Inhibitors in Dermatology
- Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
- SYSTEMATIC REVIEW OF ORAL JANUS KINASE INHIBITORS IN ALOPECIA AREATA: INSIGHTS FROM 2020 TO 2025 STUDIES
- 0350 Impact of switching janus kinase inhibitors in the treatment of severe alopecia areata
- Janus kinase inhibitor as a therapeutic option in alopecia areata. Case report
- Inhibidor janus kinasa como opción terapéutica en alopecia areata. Reporte de caso
- Community Detection and Patient Experience Analysis in Reddit Conversations on Janus Kinase Inhibitors using Large Language Models
- 72751 Janus Kinase Inhibitors for Alopecia Universalis: A Systematic Review
- Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B
- Clinical response to adjunctive platelet-rich plasma injections in a patient with alopecia universalis on oral tofacitinib
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- Deuruxolitinib for Alopecia Areata.
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Refractory alopecia universalis associated with dermatomyositis successfully treated with tofacitinib
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Topical Ruxolitinib for the Treatment of Alopecia Universalis
- JAK Inhibitors for Treatment of Alopecia Areata
- JAK inhibitors and alopecia areata
- Treatment of pediatric alopecia areata: A systematic review
- Pathomechanisms of immune-mediated alopecia